Trademark: 88518917
Status Date
Monday, February 13, 2023
Filing Date
Wednesday, July 17, 2019
Published for Opposition
Tuesday, November 12, 2019
Abandoned Date
Monday, February 13, 2023
5 Pharmaceutical and biopharmaceutical agents, namely, vaccines, immunotherapeutics, and other therapeutic agents, for the prevention and treatment of human diseases, namely, cancers, autoimmune disorders, infectious disease, transplant rejection, and inflammatory disease
Feb 13, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 13, 2023
Abandonment - No Use Statement Filed
Jul 19, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 18, 2022
Sou Extension 5 Granted
Jun 30, 2022
Sou Extension 5 Filed
Jul 18, 2022
Case Assigned To Intent To Use Paralegal
Jun 30, 2022
Sou Teas Extension Received
Jan 6, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 4, 2022
Sou Extension 4 Granted
Jan 4, 2022
Sou Extension 4 Filed
Jan 4, 2022
Sou Teas Extension Received
Jul 6, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 2, 2021
Sou Extension 3 Granted
Jul 2, 2021
Sou Extension 3 Filed
Jul 2, 2021
Sou Teas Extension Received
Jan 9, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 7, 2021
Sou Extension 2 Granted
Jan 7, 2021
Sou Extension 2 Filed
Jan 7, 2021
Sou Teas Extension Received
Jul 9, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 7, 2020
Sou Extension 1 Granted
Jul 7, 2020
Sou Extension 1 Filed
Jul 7, 2020
Sou Teas Extension Received
Jan 7, 2020
Noa E-Mailed - Sou Required From Applicant
Nov 12, 2019
Official Gazette Publication Confirmation E-Mailed
Nov 12, 2019
Published For Opposition
Oct 23, 2019
Notification Of Notice Of Publication E-Mailed
Oct 3, 2019
Approved For Pub - Principal Register
Oct 3, 2019
Assigned To Examiner
Jul 25, 2019
New Application Office Supplied Data Entered
Jul 20, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
